| Luminespib studied in …STUDIED_INderived23 of 23show fewer |
|---|
| → studied in | NCT01772797Phase 1 · completed Phase Ib Study of LDK378 and AUY922 in ALK-rearranged Non-small Cell Lung Cancer · 23 trials list this drug (0 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00526045Phase 1/Phase 2 · completed Phase I-II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 in Advanced Solid Malignancies, and Efficacy in HER2+ or ER+ Locally Advanced or Metastatic Breast Cancer Patients · 23 trials list this drug (0 active) | — | — | Hematopoietic and Lymphoid Cell Neoplasm,Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00708292Phase 1/Phase 2 · completed A Phase I-Ib/II Study to Determine the Maximum Tolerated Dose (MTD) of AUY922 Alone and in Combination With Bortezomib, With or Without Dexamethasone, in Patients With Relapsed or Refractory Multiple Myeloma. · 23 trials list this drug (0 active) | — | — | Multiple Myeloma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01084330Phase 2 · completed Phase II Trial of AUY922 vs. Comparators in Advanced Gastric Cancer · 23 trials list this drug (0 active) | — | — | Gastric Neoplasm,Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01402401Phase 2 · terminated Phase II of AUY922 in Second-line Gastric Cancer in Combination With Trastuzumab in HER2 Positive Patients · 23 trials list this drug (0 active) | — | — | Malignant Gastric Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01132625Phase 1 · completed Dose Escalation Study of AUY922 in Advanced Solid Malignancies in Japan · 23 trials list this drug (0 active) | — | — | Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01613950Phase 1 · completed PI3K Inhibitor BYL719 in Combination With the HSP90 Inhibitor AUY922 in Patients With Advanced or Metastatic Gastric Cancer · 23 trials list this drug (0 active) | — | — | not mapped | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01271920Phase 1/Phase 2 · completed Combination of AUY922 With Trastuzumab in HER2+ Advanced Breast Cancer Patients Previously Treated With Trastuzumab · 23 trials list this drug (0 active) | — | — | HER2-Positive Breast Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01784640Phase 1 · completed Pemetrexed Disodium and Hsp90 Inhibitor AUY922 in Treating Patients With Previously Treated Stage IV Non-Small Cell Lung Cancer · 23 trials list this drug (0 active) | — | — | Lung Non-Small Cell Carcinoma,Lung Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01259089Phase 1/Phase 2 · completed Hsp90 Inhibitor AUY922 and Erlotinib Hydrochloride in Treating Patients With Stage IIIB-IV Non-Small Cell Lung Cancer · 23 trials list this drug (0 active) | — | — | Lung Non-Small Cell Carcinoma,Lung Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01646125Phase 2 · terminated An Open-label, Randomized Phase II Study to Evaluate the Efficacy of AUY922 vs Pemetrexed or Docetaxel in NSCLC Patients With EGFR Mutations · 23 trials list this drug (0 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01484860Phase 2 · terminated Study of AUY922 in Metastatic Pancreatic Cancer Who Are Resistant to First Line Chemotherapy · 23 trials list this drug (0 active) | — | — | Pancreatic Neoplasm,Pancreatic Adenocarcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01922583Phase 2 · completed AUY922 in Patient With Stage IV NSCLC · 23 trials list this drug (0 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01854034Phase 2 · completed Phase 2 Study of AUY922 in NSCLC Patients With Exon 20 Insertion Mutations in EGFR · 23 trials list this drug (0 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01752400Phase 2 · completed AUY922 for Advanced ALK-positive NSCLC · 23 trials list this drug (0 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01361945Phase 1/Phase 2 · withdrawn AUY922 With Lapatinib and Letrozole for ER+ HER2+ Advanced Breast Cancer · 23 trials list this drug (0 active) | — | — | Malignant Breast Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01485536Phase 2 · terminated A Study of the HSP90 Inhibitor AUY922 · 23 trials list this drug (0 active) | — | — | Lymphoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01404650Phase 2 · completed Study of Hsp90 Inhibitor AUY922 for the Treatment of Patients With Refractory Gastrointestinal Stromal Tumor · 23 trials list this drug (0 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01668173Phase 2 · terminated HSP90 Inhibitor, AUY922, in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), Post-Essential Thrombocythemia Myelofibrosis (Post-ET MF), and Refractory PV/ET · 23 trials list this drug (0 active) | — | — | Myeloproliferative Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01124864Phase 2 · completed A Study of AUY922 in Non-small-cell Lung Cancer Patients Who Have Received Previous Two Lines of Chemotherapy. · 23 trials list this drug (0 active) | — | — | Lung Non-Small Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01294826Phase 1 · completed Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer · 23 trials list this drug (0 active) | — | — | Colon Adenocarcinoma,Malignant Colon Neoplasm,Malignant Rectal Neoplasm+1 | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01389583Phase 2 · unknown A Study of AUY922 for GIST(Gastrointestinal Stromal Tumor) Patients · 23 trials list this drug (0 active) | — | — | Gastrointestinal Stromal Tumor | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01602627Phase 1 · terminated Hsp90 Inhibitor AUY922 in Treating Older Patients With Advanced Solid Malignancies · 23 trials list this drug (0 active) | — | — | Adult Solid Neoplasm | 1 | Observed | clinicaltrials | graph → |